Canaccord Genuity Group Cuts Aspen Aerogels (NYSE:ASPN) Price Target to $5.00

Aspen Aerogels (NYSE:ASPNFree Report) had its price target decreased by Canaccord Genuity Group from $10.00 to $5.00 in a research report report published on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the construction company’s stock.

A number of other analysts have also issued reports on the stock. Barclays dropped their price target on shares of Aspen Aerogels from $6.00 to $4.00 and set an “underweight” rating for the company in a research note on Friday. Weiss Ratings reissued a “sell (d)” rating on shares of Aspen Aerogels in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Aspen Aerogels currently has an average rating of “Hold” and an average price target of $12.67.

View Our Latest Report on ASPN

Aspen Aerogels Trading Down 6.4%

NYSE:ASPN opened at $3.85 on Friday. The stock has a market cap of $316.67 million, a price-to-earnings ratio of -1.01 and a beta of 2.85. Aspen Aerogels has a one year low of $3.70 and a one year high of $17.56. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. The business’s 50-day simple moving average is $7.29 and its 200 day simple moving average is $6.78.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its quarterly earnings data on Thursday, November 6th. The construction company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business had revenue of $73.02 million for the quarter, compared to analyst estimates of $73.42 million. During the same quarter last year, the business earned ($0.17) EPS. Aspen Aerogels’s revenue for the quarter was down 37.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -4.150–4.050 EPS. As a group, sell-side analysts predict that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.

Insider Transactions at Aspen Aerogels

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of Aspen Aerogels stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the completion of the transaction, the chief accounting officer owned 19,879 shares of the company’s stock, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. 4.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently added to or reduced their stakes in ASPN. Vanguard Group Inc. boosted its holdings in shares of Aspen Aerogels by 0.5% during the third quarter. Vanguard Group Inc. now owns 4,510,370 shares of the construction company’s stock valued at $31,392,000 after acquiring an additional 22,686 shares during the period. Needham Investment Management LLC lifted its position in Aspen Aerogels by 14.5% in the 1st quarter. Needham Investment Management LLC now owns 2,737,200 shares of the construction company’s stock valued at $17,491,000 after purchasing an additional 347,500 shares during the last quarter. AWM Investment Company Inc. boosted its stake in Aspen Aerogels by 102.6% during the 1st quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company’s stock valued at $15,651,000 after purchasing an additional 1,240,535 shares during the period. Gagnon Securities LLC acquired a new position in Aspen Aerogels during the 2nd quarter valued at about $11,243,000. Finally, Federated Hermes Inc. bought a new position in Aspen Aerogels in the 2nd quarter worth about $10,459,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Further Reading

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.